Novo Nordisk A/S Share Price & Technical Analysis
NVO · $43.96 (+2.69%)
Healthcare / Drug Manufacturers - General
$43.96
+2.69%
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in…
Price chart
Seasonality
Jun has 3 positive and 2 negative years (last 5 years shown)
-3% return in Jun, 2% avg return in past 3 year Jun month.
-3% return in 2026, -5% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 15% | -35% | 0% | 15% | 5% | -3% | – | – | – | – | – | – | -3% |
| 25 | -4% | 10% | -23% | -5% | 4% | -4% | -31% | 17% | -2% | -12% | 0% | 4% | -46% |
| 24 | 13% | 5% | 5% | -1% | 6% | 7% | -8% | 5% | -14% | -6% | -5% | -21% | -14% |
| 23 | 1% | 1% | 12% | 5% | -4% | 3% | 1% | 15% | -3% | 7% | 5% | 2% | 44% |
| 22 | -9% | 2% | 7% | 2% | -3% | 1% | 6% | -9% | -5% | 7% | 15% | 7% | 20% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Uptrend
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides NovoPen 6 and NovoPen Echo Plus, smart insulin pens; Dose Check, an insulin dose guidance application; growth hormone pens and injection needles; and Wegovy pill an oral glucagon-like peptide-1 (GLP-1) receptor agonist therapy for weight management. It operates in Europe, Canada, the United States, Japan, Korea, Oceania, Southeast Asia, Mainland China, Hong Kong and Taiwan, Latin America, the Middle East, and Africa. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$191.45B
P/E ratio
10.15
52W high
$81.44
52W low
$35.12
Volume
1,25,99,424
Beta
0.35
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹35,920
Abbott Laboratories Cede…
₹33,540
Eli Lilly And Company Ce…
₹30,700
Unitedhealth Group Inc C…
₹18,590
₹7,059
Frequently asked questions
- What is Novo Nordisk A/S share price today?
- Novo Nordisk A/S (NVO) last traded around $43.96 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does NVO have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for NVO. Download the app for real-time alerts.
- How can I analyze Novo Nordisk A/S stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.